Microgen Bioproducts® SARS-CoV-2 IgG EIA – Lab Innovations UK

Microgen Bioproducts® SARS-CoV-2 IgG EIA

Description​

Microgen Bioproducts® SARS-CoV-2 IgG EIA

The Microgen Bioproducts® SARS-CoV-2 IgG EIA is a high-performance ELISA test for the qualitative detection of IgG antibodies. The test is intended for screening patients suspected of being infected with the SARS-CoV-2 virus.
• Accurate detection of SARS-CoV-2 IgG antibodies
• High Sensitivity and Specificity
• <1 hour 30 minutes incubation time • Functional with human plasma and serum samples • No cross-reactivity with common viral pathogens • Validated for manual application, however also suitable for high throughput ELISA automation • No additional reagents required

Scroll to Top